Arvinas, Inc (NASDAQ: ARVN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARVINAS, INC

Arvinas, Inc (NASDAQ: ARVN)
Listen to this Section


$7.51
-0.2310 ( -2.98% ) 353.0K

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Market Data


Open $7.51
Previous Close $7.74
Volume 353.0K
Market Cap $499.39M
Day Range $7.51 - $7.87
52 Week Range $6.06 - $14.51
Shares Outstanding 64.52M
Change % -2.98%
Net Change ▼ -0.2310
Insider Ownership N/A
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2018
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -46,409.00

Date Type Amount Purchased Purchaser
2025-09-24 Buy 30000.00 Morrison Briggs
2025-09-24 Buy 30000.00 Morrison Briggs
2024-06-26 Sale -61409.00 Saik Andrew
2024-02-27 Sale -5750.00 Loomis David K
2024-02-27 Sale -39250.00 Taylor Ian

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 27, 2025
4 Insider transactions 1 Jun 24, 2025
4 Insider transactions 1 Jun 18, 2025
8-k 8K-related 17 Jun 13, 2025
8-k 8K-related 12 Jun 06, 2025
8-k 8K-related 16 Jun 06, 2025
8-k 8K-related 19 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy